Trial
NCT00167791
Rituximab Desensitization Therapy for Patients on the Waiting List for Kidney Transplant
UnknownWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
University of Wisconsin, Madison
Collaborators
Genentech, Inc.
Condition
End Stage Renal Disease
Intervention
rituximab
Why stopped
lack of enrollment
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2015-10-14